Cynthia Wetmore, MD, Pediatric Hematology & Oncology, Alameda, CA

CynthiaJWetmoreMDPhD

Pediatric Hematology & Oncology Alameda, CA

Pediatric Neuro-Oncology

Senior Medical Director, Clinical Development Exelixis, Inc. 1851 Harbor Bay Parkway Alameda, CA 94502

Dr. Wetmore is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Wetmore's full profile

Already have an account?

  • Office

    Senior Medical Director, Clinical Development, Exelixis, Inc
    1851 Harbor Bay Parkway
    Alameda, CA 94502
    Phone(901) 262-7483
  • Is this information wrong?

Summary

  • Dr. Cynthia Wetmore is a pediatric hematologist/oncologist in Phoenix, AZ and is affiliated with Phoenix Children's Hospital. She received her medical degree from University of Minnesota Medical School and has been in practice 22 years. She specializes in pediatric neuro-oncology and is experienced in pediatric neuro-oncology, clincial trials, and translational research.

Skills & Expertise

  • Pediatric neuro-oncology, Clincial trials, Translational Research

Education & Training

  • Mayo School of Graduate Medical Education
    Mayo School of Graduate Medical EducationResidency, Pediatrics, 2001 - 2002
  • St Jude Childrens Res Hospital
    St Jude Childrens Res HospitalFellowship, Pediatric Hematology/Oncology, 1997 - 2001
  • University of Minnesota
    University of MinnesotaResidency, Pediatrics, 1995 - 1997
  • University of Minnesota Medical School
    University of Minnesota Medical SchoolClass of 1995
  • Karolinska InstitutetPhD, Histology and Neurobiology, 1992
  • Harvard UniversityB.A., History of Science, Magna Cum Laude, 1986

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 2017 - 2022
  • GA State Medical License
    GA State Medical License 2014 - 2020
  • TN State Medical License
    TN State Medical License 2010 - 2014
  • MN State Medical License
    MN State Medical License 2001 - 2022
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Award for basic/translational science International Society for Pediatric Oncology (SIOP), 2007
  • Distinguished Scientist Award Sontag Foundation, 2004
  • Award for Excellence in Teaching Mayo College of Medicine, 2003
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Phase I trial, pharmacokinetics and pharmacodynamics of vandetanib and dasatanib in children with newly diagnosed diffuse intrinsic pontine glioma  
    Broniscer A, Baker SD, Wetmore C, Pai-Panandiker A, Huang J, Davidoff AM, Onar-Thomas A, Panetta JC, Chin TK, Merchant TE, Baker JN, Kaste SC, Gajjar A, Stewart CF, Clin Cancer Res, 1/27/2013
  • Determination of crenolanib in human serum and cerebrospinal fluid by liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS)  
    Roberts MS, Turner DC, Owens TS, Ramachandran A, Wetmore C, Throm SL, Stewart CF, J Chromatogr B Analyt Technol Biomed Life Sci, 1/15/2013
  • Diffuse leptomemingeal gliomatosis  
    Jicha GA, Glantz J, Clarke MJ, Lehwald LM Russo DP, Giannini C, Wald JT, Uhm J, Kumar N, Aksamit AJ, Wetmore CJ, Eur Neurol, 1/1/2009
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • First in Pediatrics Phase I study of crenolanib (CP-868,596) administered during and after radiation therapy (RT) in newly-diagnosed diffuse intrinsic pontine glioma (...
    Wetmore, C., Broniscer, A., Wright, K., Armstrong, G., Baker, J., Kun, L., Patay, Z., Onar-Thomas, A., Ramachandran, A., Turner, D., Gajjar, A., Stewart, C, ASCO Annual Meeting, Chicago, IL, 1/1/2014
  • A Phase I trial of MK-0752 in Pediatric Patients with Recurrent or Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study.
    M. Fouladi, J. Olson, C.F. Stewart, M. Kocak, A. Onar-Thomas, L. Wagner, R. J. Packer, S. Goldman, S. Gururangan, S. M. Blaney, I. Pollack, C. Smith, A. Gajjar, T. Dem..., SNO Annual Meeting, 1/1/2013
  • Activity of alisertib (MLN8237) as single agent in recurrent atypical teratiod tumor (ATRT) in four children: a single patient treatment plan pilot study.
    Wetmore C, Bendel A, Gajjar A, Rhabdoid Tumors: Integrating biological insights with clinical successes. Institut Curie, Paris, France, 1/1/2013
  • Join now to see all

Lectures

  • The Cancer Answer: Progress and Possibilities 
    Woodruff Arts Center, Atlanta, GA - 1/1/2014
  • Research 101: Tissue acquisition and Bio-banking. 
    1/1/2014
  • Bridging the Gap: Translating basic research into new approaches in clinical care. 
    Portsmouth, UK - 1/1/2013
  • Join now to see all

Press Mentions

  • Fertility Preservation for Pediatric and Adolescent Patients with Cancer: Medical and Ethical Considerations
    Fertility Preservation for Pediatric and Adolescent Patients with Cancer: Medical and Ethical ConsiderationsMarch 2nd, 2020
  • Gilbert Girl, 7, Takes on Battle for Her Life
    Gilbert Girl, 7, Takes on Battle for Her LifeSeptember 6th, 2019
  • Gateway for Cancer Research Approves $1.5 Million Grant to Fund Pediatric Brain Cancer Study at Phoenix Children's Hospital
    Gateway for Cancer Research Approves $1.5 Million Grant to Fund Pediatric Brain Cancer Study at Phoenix Children's HospitalApril 11th, 2019
  • Join now to see all

Professional Memberships